IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Earning Conference on audited financial results for Q1FY2419-08-2023
19-08-2023
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q1FY2416-08-2023
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of lost share certificates16-08-2023
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation - Q1FY2414-08-2023
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2105, this is to inform you that the Company is organizing an analyst /investor conference call on Wednesday, 16th August, 2023 at 4:00 PM (IST) to discuss the financial performance of the Company for the Q1FY24.14-08-2023
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Summary of the proceedings of 36th Annual General Meeting held on 10th August 202310-08-2023
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Submission of Voting Results along with Scrutinizer''s Report with regard to the 36th Annual General Meeting10-08-2023
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of newspaper publication of Audited Financial Results for the quarter ended 30th June 202310-08-2023
Q1FY24 Quarterly Result Announced for IOL Chemicals and Pharmaceuticals Ltd.
IOL Chemicals and Pharmaceuticals announced Q1FY24 results: Total income for Q1FY24 stood at Rs 570 crore at the same level of Rs 570 crore in Q1FY23 EBITDA for Q1FY24 at Rs 80 crore as compared to Rs 61 crore in Q1FY23 Net profit for Q1FY24 at Rs 46 crore as compared to Rs 35 crore in Q1FY23 Commenting on the performance, Vikas Gupta, Joint Managing Director, said, “We are pleased to report sustainable performance during Q1FY24, tackling present challenges while positioning ourselves for forthcoming opportunities. We are hopeful for an increased presence in regulatory markets as the Company got CEP for paracetamol. Additionally, with the commencement of the Acetic Anhydride plant, focus on improved efficiencies, product mix, and timely execution we are hopeful to generate strong cash flow”. Result PDF10-08-2023
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release for Financial Results Q1 FY2409-08-2023